Metacrine, Inc.

Ownership Transactions Reported by 24 Insiders

Industry
Pharmaceutical Preparations
Location
4225 Executive Square, Suite 600, San Diego, California

There are no Buy or Sell transactions made by insiders since 9/9/2023

Metacrine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M. Leonard 10%+ Owner $3.18M Dec 19, 2022
Ali Behbahani 10%+ Owner $1.2M Dec 10, 2021
Carmen Chang 10%+ Owner $1.2M Dec 10, 2021
Anthony A. Florence Jr. 10%+ Owner $1.2M Dec 10, 2021
Mohamad Makhzoumi 10%+ Owner $1.2M Dec 10, 2021
Peter W. Sonsini 10%+ Owner $1.2M Dec 10, 2021
Scott D. Sandell 10%+ Owner $1.2M Dec 10, 2021
Paul Edward Walker 10%+ Owner $1.2M Dec 10, 2021
New Enterprise Associates 16, L.P. 10%+ Owner $1.2M Dec 10, 2021
Forest Baskett 10%+ Owner $1.2M Dec 10, 2021
venBio Global Strategic Fund, L.P. 10%+ Owner $1.15M Oct 22, 2021
Preston Klassen Director $651K Mar 23, 2023
Trisha Millican Chief Financial Officer $51.2K May 5, 2021
Michael York Chief Business Officer $48.6K Jan 26, 2023
Catherine C. Lee EVP, Gen. Counsel & Secretary $1.81K May 5, 2021
Hubert C. Chen Chief Medical Officer $1.55K May 20, 2021
Jeffrey David Jonker Director May 18, 2022
Amir Nashat Director, 10%+ Owner May 18, 2022
Julia C. Owens Director May 18, 2022
Ronald M. Evans Director May 18, 2022
Richard A. Heyman Director May 18, 2022
Kristina Burow Director May 24, 2021
Andrew Guggenhime Director May 18, 2022
John G. McHutchison Director May 18, 2022

Recent Insider Transactions by Companies or Individuals for Metacrine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.